Enhancement of antigen‐presenting ability of B lymphoma cells by partial inhibition of protein synthesis through inducing B7‐1 expression
Open Access
- 1 June 1997
- journal article
- Published by Wiley in Immunology
- Vol. 91 (2) , 212-218
- https://doi.org/10.1046/j.1365-2567.1997.00253.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.The Journal of Experimental Medicine, 1995
- Identification of an Alternatively Spliced Form of the Murine Homolog of B7Biochemical and Biophysical Research Communications, 1994
- Expression and Functional Analysis of Murine B7 Delineated by a Novel Monoclonal AntibodyCellular Immunology, 1994
- Enhancement of inducible-type NO synthase gene transcription by protein synthesis inhibitorsFEBS Letters, 1994
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.The Journal of Experimental Medicine, 1992
- The costimulatory function of antigen-presenting cellsImmunology Today, 1990
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989
- B cells as antigen-presenting cells: Antibody production in vitro against a T-dependent antigenCellular Immunology, 1986
- Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probesCell, 1980